A bad trip: Oxford Cannabinoid to delist from ‘turbulent’ London markets
Oxford Cannabinoid Technologies has announced plans to delist from the London Stock Exchange, in another blow for the embattled bourse. The biopharma firm, which makes painkillers using cannabis, said continued…